Lexaria Bioscience Corp. ( LEXX) - Key Metrics
LEXX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | ? | ? | ? | ? |
| 2026Q2 | ? | ? | ? | ? |
| 2026Q1 | ? | -$0.07 | -$0.05 | -$0.05 |
| 2025Q4 | $0.01 | -$0.14 | -$0.14 | -$0.14 |
| 2025Q3 | $0.01 | -$0.21 | -$0.20 | -$0.20 |
LEXX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | ? | ? |
| 2026Q2 | ? | ? |
| 2026Q1 | ? | -3.55 |
| 2025Q4 | ? | -1.60 |
| 2025Q3 | ? | -1.23 |
LEXX
Price: $0.40
52 week price:
Earnings Per Share: -0.34 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 7400
Market Capitalization: 15.8 million